Tivic Health Systems Inc

For the period ended Dec 31, 2023. Filed Mar 25, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 25, 2024

VBIO$0.54+6.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheets

December 31, 2023 and 2022

(in thousands, except share and per share data)

	December 31,2023	December 31,2022
ASSETS
Current assets
Cash and cash equivalents	$3,395	$3,517
Accounts receivable, net	174	107
Inventory, net	756	863
Deferred offering costs	—	584
Prepaid expenses and other current assets	327	235
Total current assets	4,652	5,306
Property and equipment, net	122	12
Right-of-use assets, operating lease	349	523
Other assets	34	34
Total assets	$5,157	$5,875
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable	$713	$1,323
Other accrued expenses	495	392
Operating lease liability, current	193	163
Total current liabilities	1,401	1,878
Operating lease liability	176	367
Total liabilities	1,577	2,245
Commitments and contingencies (Note 6)
Stockholders’ equity
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding at December 31, 2023 and 2022, respectively	—	—
Common stock, $0.0001 par value, 200,000,000 shares authorized; 1,466,092 and 96,778 shares issued and outstanding at December 31, 2023 and 2022, respectively	—	—
Additional paid in capital	41,466	33,272
Accumulated deficit	(37,886)	(29,642)
Total stockholders’ equity	3,580	3,630
Total liabilities and stockholders’ equity	$5,157	$5,875

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.